Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · MA, NY · Nov 5, 2009 → Apr 23, 2015
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Mitchell S. Bloom is listed as an executive officer on 26 SEC Form D filings by 12 issuers between Oct 2009 and Feb 2019. Largest by amount reported sold: Larimar Therapeutics, Inc. (Bala Cynwyd, PA — biotechnology — 2010–2012; $82.1M reported sold to 24 investors), Naurex Inc. (Evanston, IL — pharmaceuticals — 2011–2014; $80M reported sold to 61 investors), Axon Therapies Inc. (New York, NY — other technology — 2016–2019; $75M reported sold to 10 investors), Voyager Therapeutics, Inc. (Lexington, MA — biotechnology — 2015; $60M reported sold to 10 investors), Mevion Medical Systems, Inc. (Littleton, MA — biotechnology — 2015; $58.8M reported sold to 18 investors) and 7 more (all listed below).
What this means That is a lot of deals — 12 separate companies raised money with this person listed as executive officer, over about 10 years. Across those companies the filings report $471.1M sold in total.
Listed alongside Kevin Starr (7 shared filings), Mark Gelfand (7 shared filings), Ashish Khanna (5 shared filings), Bruce Booth (5 shared filings), James Schulz (5 shared filings) and 74 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mitchell. Each name links to their own page.
1 of the issuers belongs to the sponsor group Cure (3 issuers, $353.6M reported sold, 2011–2025).
What this means A sponsor group is one team that sets up a new company for each deal. Cure has 3 companies on file and $353.6M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 3 bankruptcy cases matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 26 public filings for Mitchell S. Bloom and found 10 differences, 3 worth asking the sponsor about: Regulator action naming a team member: Ankit Mahadevia and Satyavrat Shukla (Jan 16, 2026); Amount sold went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Mitchell S. Bloom has not run yet — it is joining a line of 40,198 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.
Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.
Five things investors ask first. Items still in human review are counted, not shown.
None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Mitchell S. Bloom..
State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).
3 cases: 3 closed (disposition not in docket feed)
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
10 differences found between the filings for Mitchell S. Bloom — 3 worth asking about (compared 26 filings on Oct 24, 2026)
A ap release dated Jan 16, 2026 names Ankit Mahadevia (listed on the same filings). The release is the source; we do not summarize its outcome here.
What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.
The Feb 7, 2019 filing says $74,999,993 sold; the Feb 7, 2019 Form D/A says $7,499,994 sold — $67,499,999 less.
What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.
Axon Therapies Inc. (last filing Feb 7, 2019; $74,999,993 sold of $150,000,000); Ember Therapeutics, Inc. (last filing Dec 21, 2011; $3,190,608 sold of $34,190,608); RaNA Therapeutics, Inc. (last filing Nov 30, 2011; $2,665,000 sold of $20,665,000). Each has no filing in more than two years and reported under half its target sold.
What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.
The filing says the first sale was Jul 24, 2015. The Form D was filed Aug 11, 2015 — 18 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 3 days past that.
What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.
No amendment in the last 12 months on an offering that may still be open — Axon Therapies Inc. (latest filing Feb 7, 2019) · No amendment in the last 12 months on an offering that may still be open — Axon Therapies Inc. (latest filing Jun 28, 2017) · No amendment in the last 12 months on an offering that may still be open — Mevion Medical Systems, Inc. (latest filing Aug 11, 2015) · No amendment in the last 12 months on an offering that may still be open — Voyager Therapeutics, Inc. (latest filing Apr 23, 2015) · No amendment in the last 12 months on an offering that may still be open — Naurex Inc. (latest filing Dec 3, 2014) · and 14 more
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
Offering amount lowered between filings — Axon Therapies Inc. · Offering amount changed between filings — Coridea NC1, Inc. · Offering amount changed between filings — Naurex Inc. · Offering amount changed between filings — Afferent Pharmaceuticals, Inc.
What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.
listed as "Mitchell Bloom" on 6 filings (from Oct 8, 2009), and "Mitchell S. Bloom" on 20 filings (from Nov 5, 2009).
What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.
"Biotechnology" (Jul 8, 2009 to May 14, 2014); then "Pharmaceuticals" (Dec 3, 2014).
What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.
The people listed on the Oct 17, 2011 filing give Teaneck, NJ; on the Jun 7, 2012 filing they give New York, NY.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
MA on 22 filings (Oct 8, 2009 to Aug 11, 2015); NY on 4 filings (Apr 19, 2016 to Feb 7, 2019).
What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
None reported on 22 offerings — no sales commissions, finder's fees or proceeds to insiders
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Feb 7, 2019 D/A Axon Therapies Inc. File 021-332379 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 28, 2017 D Axon Therapies Inc. File 021-289607 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 19, 2016 D Axon Therapies Inc. File 021-261599 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 11, 2015 D Mevion Medical Systems, Inc. File 021-245473 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 23, 2015 D Voyager Therapeutics, Inc. File 021-238528 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 3, 2014 D Naurex Inc. File 021-229372 | $0 | $0 | $0 The Issuer will use proceeds for general working capital purposes, which includes payments to its executive officers and other employees in the ordinary course of business. | None listed on this filing | EDGAR ↗ |
| May 14, 2014 D Naurex Inc. File 021-217398 | $0 | $0 | $0 The Issuer will use proceeds for general working capital purposes, which includes payments to its executive officers and other employees in the ordinary course of business. | None listed on this filing | EDGAR ↗ |
| Aug 7, 2013 D Edimer Pharmaceuticals, Inc. File 021-200941 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 21, 2012 D Naurex Inc. File 021-188867 | $0 | $0 | $0 The Issuer will use proceeds for general working capital purposes, which includes payments to its executive officers and other employees in the ordinary course of business. | None listed on this filing | EDGAR ↗ |
| Dec 5, 2012 D Larimar Therapeutics, Inc. File 021-187910 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 28, 2012 D Larimar Therapeutics, Inc. File 021-183316 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 7, 2012 D Coridea NC1, Inc. File 021-179426 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 21, 2011 D Ember Therapeutics, Inc. File 021-170448 | $0 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Nov 30, 2011 D RaNA Therapeutics, Inc. File 021-169407 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Nov 29, 2011 D Selventa, Inc. File 021-169318 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Oct 17, 2011 D/A Coridea NC1, Inc. File 021-152096 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 12, 2011 D Larimar Therapeutics, Inc. File 021-162666 | $0 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| May 19, 2011 D Naurex Inc. File 021-160088 | $0 | $0 | $0 The Issuer will use proceeds for general working capital purposes, which includes payments to its executive officers and other employees in the ordinary course of business. | None listed on this filing | EDGAR ↗ |
| Feb 4, 2011 D/A Naurex Inc. File 021-132513 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 2, 2010 D/A Larimar Therapeutics, Inc. File 021-94401 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 18, 2009 D Afferent Pharmaceuticals, Inc. File 021-135875 | $0 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Oct 8, 2009 D NinePoint Medical, Inc. File 021-135073 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Mitchell S. Bloom on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $75M from 10 investors (100% of the $15M target) as of the latest filing. Mitchell is listed as executive officer on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $58.8M from 18 investors as of the latest filing. Mitchell is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $60M from 10 investors as of the latest filing. Mitchell is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $80M from 61 investors as of the latest filing. Mitchell is listed as executive officer on 5 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $9.79M from 5 investors (54% of the $18M target) as of the latest filing. Mitchell is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $82.1M from 24 investors as of the latest filing. Mitchell is listed as executive officer on 5 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $5M from 3 investors (50% of the $10M target) as of the latest filing. Mitchell is listed as executive officer on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $3.19M from 1 investor (9% of the $34.2M target) as of the latest filing. Mitchell is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $2.67M from 4 investors (13% of the $20.7M target) as of the latest filing. Mitchell is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $4.96M from 9 investors as of the latest filing. Mitchell is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $55M from 17 investors (100% of the $23M target) as of the latest filing. Mitchell is listed as executive officer on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $34.6M from 3 investors (100% of the $33.2M target) as of the latest filing. Mitchell is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.
Kevin Starr is on 9 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Peter Barrett is on 12 issuers in total — a repeat sponsor. Their page lists every one.
Bruce Booth is on 21 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Ashish Khanna is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Louis Tartaglia is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Paul LaViolette is on 20 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Terry Gould is on 11 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
David Neafus is on 11 issuers in total — a repeat sponsor. Their page lists every one.
Arthur M. Pappas is on 11 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Liam Ratcliffe is on 11 issuers in total — a repeat sponsor. Their page lists every one.
Kevin Gillis is on 6 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Lou Tartaglia is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
Andrew ElBardissi is on 12 issuers in total — a repeat sponsor. Their page lists every one.
Jesse Treu is on 10 issuers in total — a repeat sponsor. Their page lists every one.
Steven Hochberg is on 12 issuers in total — a repeat sponsor. Their page lists every one.
Russell Hirsch is on 12 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Mitchell S. Bloom. Their page shows their other deals.
One team, 3 deal companies. Mitchell S. Bloom is listed on 1 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Mitchell S. Bloom.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).
None of the 12 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Mitchell S. Bloom by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 12 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Mitchell S. Bloom is listed on: none on file. No website or social profile named in Voyager Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #108,221 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (Lexington, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Mitchell S. Bloom appears on a new Form D, or when a court case or SEC action is matched to them. See plans →